These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18446511)

  • 1. Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model.
    Fleischer S; Sharkey M; Mealey K; Ostrander EA; Martinez M
    AAPS J; 2008; 10(1):110-9. PubMed ID: 18446511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethics and genetic selection in purebred dogs.
    Meyers-Wallen VN
    Reprod Domest Anim; 2003 Feb; 38(1):73-6. PubMed ID: 12535334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics.
    Martinez MN; Antonovic L; Court M; Dacasto M; Fink-Gremmels J; Kukanich B; Locuson C; Mealey K; Myers MJ; Trepanier L
    Drug Metab Rev; 2013 May; 45(2):218-30. PubMed ID: 23432217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and distribution of 152 genetic disease variants in over 100,000 mixed breed and purebred dogs.
    Donner J; Anderson H; Davison S; Hughes AM; Bouirmane J; Lindqvist J; Lytle KM; Ganesan B; Ottka C; Ruotanen P; Kaukonen M; Forman OP; Fretwell N; Cole CA; Lohi H
    PLoS Genet; 2018 Apr; 14(4):e1007361. PubMed ID: 29708978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine cytochrome P-450 pharmacogenetics.
    Court MH
    Vet Clin North Am Small Anim Pract; 2013 Sep; 43(5):1027-38. PubMed ID: 23890236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues related to the use of canines in toxicologic pathology--issues with pharmacokinetics and metabolism.
    Tibbitts J
    Toxicol Pathol; 2003; 31 Suppl():17-24. PubMed ID: 12597427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of genetic variation in 28 dog breed populations with 100 microsatellite markers.
    Irion DN; Schaffer AL; Famula TR; Eggleston ML; Hughes SS; Pedersen NC
    J Hered; 2003; 94(1):81-7. PubMed ID: 12692167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage.
    Neff MW; Robertson KR; Wong AK; Safra N; Broman KW; Slatkin M; Mealey KL; Pedersen NC
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11725-30. PubMed ID: 15289602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative and veterinary pharmacogenomics.
    Mosher CM; Court MH
    Handb Exp Pharmacol; 2010; (199):49-77. PubMed ID: 20204583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly heritable and functionally relevant breed differences in dog behaviour.
    MacLean EL; Snyder-Mackler N; vonHoldt BM; Serpell JA
    Proc Biol Sci; 2019 Oct; 286(1912):20190716. PubMed ID: 31575369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breed distribution of the nt230(del4) MDR1 mutation in dogs.
    Gramer I; Leidolf R; Döring B; Klintzsch S; Krämer EM; Yalcin E; Petzinger E; Geyer J
    Vet J; 2011 Jul; 189(1):67-71. PubMed ID: 20655253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of canine microsatellites within and between different dog breeds.
    Zajc I; Mellersh CS; Sampson J
    Mamm Genome; 1997 Mar; 8(3):182-5. PubMed ID: 9069118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine: going to the dogs?
    Mealey KL; Martinez SE; Villarino NF; Court MH
    Hum Genet; 2019 May; 138(5):467-481. PubMed ID: 31032534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine Cancer Genomics: Lessons for Canine and Human Health.
    Ostrander EA; Dreger DL; Evans JM
    Annu Rev Anim Biosci; 2019 Feb; 7():449-472. PubMed ID: 30418802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine gastrointestinal physiology: Breeds variations that can influence drug absorption.
    Oswald H; Sharkey M; Pade D; Martinez MN
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):192-203. PubMed ID: 26409436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance.
    Matsunaga N; Ufuk A; Morse BL; Bedwell DW; Bao J; Mohutsky MA; Hillgren KM; Hall SD; Houston JB; Galetin A
    Drug Metab Dispos; 2019 Mar; 47(3):215-226. PubMed ID: 30593544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics.
    Martinez MN; Mochel JP; Neuhoff S; Pade D
    AAPS J; 2021 Apr; 23(3):59. PubMed ID: 33907906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in pharmacokinetics and pharmacodynamics.
    Toutain PL; Ferran A; Bousquet-Mélou A
    Handb Exp Pharmacol; 2010; (199):19-48. PubMed ID: 20204582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacogenetics: relevant aspects for the practicing veterinarian].
    Jud Schefer R; Paine Kuhn C; Demuth D
    Schweiz Arch Tierheilkd; 2012 Dec; 154(12):521-7. PubMed ID: 23188764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between radiographic assessment of hip status and subsequent incidence of veterinary care and mortality related to hip dysplasia in insured Swedish dogs.
    Malm S; Fikse F; Egenvall A; Bonnett BN; Gunnarsson L; Hedhammar A; Strandberg E
    Prev Vet Med; 2010 Feb; 93(2-3):222-32. PubMed ID: 19819036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.